Physician profile
Kevin Park
NPI 1356579627
$37,091.57
in general payments reported to CMS, 2019-2025
12 companies · $2,342 in 2025
The $2,342 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,651 · 2020: $648 · 2021: $9,484 · 2022: $13K · 2023: $2,494 · 2024: $3,307 · 2025: $2,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,309 · Travel and Lodging: $2,834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,309.11 |
| Travel and Lodging | $2,833.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $25,404.98 | 2019-2024 | |
| Globus Medical, INC. | $3,791.83 | 2024-2025 | Excelsiusgps Robotic Navigation System, Xlif, Modulus |
| Nuvasive, INC. | $2,069.69 | 2019-2023 | Acp, Xlif, Pulse |
| Medtronic, INC. | $1,734.96 | 2021-2025 | Mazor X System, Unid_pass |
| Arteriocyte Medical Systems, INC. | $1,507.11 | 2023-2025 | Magellan |
| Medical Device Business Services, INC. | $1,210.76 | 2019 | |
| Depuy Synthes Sales INC. | $491.20 | 2019-2023 | Na |
| Medtronic USA, INC. | $355.67 | 2020 | |
| Cerapedics INC. | $194.30 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Zimmer Biomet Holdings, INC. | $186.57 | 2019-2025 | Comprehensive Shoulder System |
| Abbott Laboratories | $110.37 | 2022 | |
| Vericel Corporation | $34.13 | 2023 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kevin Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.